Latest stories on RYTM
Rhythm Pharmaceuticals to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026
GlobeNewswire50 · neutralgeneral
Rhythm Pharmaceuticals to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026
Business Insider50 · neutralgeneral
William Blair initiates Rhythm Pharmaceuticals stock with outperform rating
Investing.com Analyst Ratings63 · neutralanalyst
Rhythm Pharmaceuticals initiated with an Outperform at William Blair
The Fly63 · neutralanalyst
JPMorgan trims Rhythm Pharmaceuticals target, adds to Analyst Focus List
The Fly38 · neutralanalyst
Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity
Business Insider64 · neutralproduct/pr
Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity
GlobeNewswire74 · bullishproduct/pr
H.C. Wainwright raises Rhythm Pharmaceuticals stock price target to $130 on Japan approval
Investing.com Analyst Ratings74 · bullishanalyst
Rhythm Pharmaceuticals price target raised to $150 from $149 at BofA
The Fly56 · neutralanalyst
Rhythm Pharmaceuticals price target raised to $159 from $155 at RBC Capital
The Fly61 · neutralanalyst
Kuehn Law Encourages Investors of Rhythm Pharmaceuticals, Inc. to Contact Law Firm
PR Newswire42 · neutralgeneral
Mexico Cardiac Rhythm Management Devices Market Outlook to 2036 Provides Revenue, Volume, Pricing and Competitive Insig
GlobeNewswire55 · neutralgeneral
Rhythm Pharmaceuticals initiated with an Outperform at Wolfe Research
The Fly61 · neutralanalyst
David Fullmer Reveals Why Rhythm, Not Motivation, Is the Key to Achieving Lasting Success
Barchart50 · neutralgeneral
Rhythm Pharmaceuticals, Inc. (RYTM) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralproduct/pr
Rhythm Pharmaceuticals assumed with an Outperform at Leerink
The Fly61 · neutralanalyst
Rhythm Energy Explains What Business Leaders Should Know About Texas’s Deregulated Energy Market
Barchart56 · neutralproduct/pr
Billionaire Stanley Druckenmiller’s 2 New Healthcare Stock Picks
Yahoo Finance63 · neutralgeneral
Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting
Business Insider63 · neutralproduct/pr
Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting
GlobeNewswire63 · neutralproduct/pr
Rhythm Completes Acquisition of Newly Established Plating Subsidiary
TipRanks62 · neutralm&a
Rhythm Pharmaceuticals initiated with a Hold at Deutsche Bank
The Fly50 · neutralanalyst